Vanguard Group Inc Biote Corp. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Biote Corp. stock. As of the latest transaction made, Vanguard Group Inc holds 1,404,914 shares of BTMD stock, worth $9.36 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,404,914
Previous 1,419,529
1.03%
Holding current value
$9.36 Million
Previous $7.01 Million
16.2%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding BTMD
# of Institutions
56Shares Held
12.8MCall Options Held
0Put Options Held
0-
325 Capital LLC New York, NY3.77MShares$25.1 Million10.43% of portfolio
-
Bandera Partners LLC New York, NY2.01MShares$13.4 Million4.63% of portfolio
-
Black Rock Inc. New York, NY973KShares$6.48 Million0.0% of portfolio
-
Kanen Wealth Management LLC Coral Springs, FL838KShares$5.58 Million3.21% of portfolio
-
Boston Partners Boston, MA714KShares$4.75 Million0.01% of portfolio
About biote Corp.
- Ticker BTMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 7,574,270
- Market Cap $50.4M
- Description
- biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...